Eight University of Washington researchers are among the 396 new fellows of the American Association for the Advancement of Science, announced this week.
Tag: Matt Kaeberlein
Rapamycin, an anti-rejection drug for organ transplant patients, has now been shown to increases survival in and delayed symptoms of Leigh’s syndrome. The drug appears to cause a metabolic switch that bypasses the mitochondrial deficiency.